Skip to main content

Advertisement

Log in

Utility of Circulating Tumor DNA in Appendiceal Tumors

  • Research Communication
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Chaudhuri AA, Chabon JJ, Lovejoy AF, et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. Cancer Discovery. 2017;7(12):1394-1403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dawson S-J, Tsui DW, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. New England Journal of Medicine. 2013;368(13):1199-1209.

    Article  CAS  PubMed  Google Scholar 

  3. Raja R, Kuziora M, Brohawn PZ, et al. Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab. Clinical Cancer Research. 2018;24(24):6212-6222.

    Article  CAS  PubMed  Google Scholar 

  4. Tie J, Cohen JD, Wang Y, et al. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. JAMA Oncol. 2019;5(12):1710-1717.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Baumgartner JM, Raymond VM, Lanman RB, et al. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. Ann Surg Oncol. 2018;25(8):2400-2408.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dhiman A, Kothary V, Witmer HDD, et al. Role of Tumor-informed Personalized ctDNA Assay in Informing Recurrence in Patients with Peritoneal Metastases from Colorectal and High-grade Appendix Cancer Undergoing Curative Intent Surgery. Ann Surg. 2023.

Download references

Acknowledgements

The authors would like to acknowledge Natera, Inc. for providing custom ctDNA testing as part of an institution-wide collaboration with MD Anderson Cancer Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael G. White.

Ethics declarations

Conflict of Interest

E.S. is an employee at Natera, Inc. with stock or option to own stock. Other authors claim no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhutiani, N., Helmink, B.A., Zeineddine, M. et al. Utility of Circulating Tumor DNA in Appendiceal Tumors. J Gastrointest Surg 27, 3071–3073 (2023). https://doi.org/10.1007/s11605-023-05825-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-023-05825-3

Keywords

Navigation